Biopharmaceutical Excipients Market Report 2026

Biopharmaceutical Excipients Market Overview

• Biopharmaceutical Excipients market size has reached to $3.27 billion in 2025 • Expected to grow to $5.04 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Surge In Demand Of Vaccine Development Fueling The Growth Of The Market Due To Increasing Immunization Coverage And Government Initiatives • Market Trend: Technological Innovations In High-Purity Surfactants For Enhanced Biopharmaceutical Formulations • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biopharmaceutical Excipients Market?

Biopharmaceutical excipients are inactive substances formulated alongside active pharmaceutical ingredients to aid in the development, stability, and delivery of biologic drugs. They enhance the effectiveness, safety, and shelf-life of biopharmaceutical products without exerting therapeutic effects themselves. These excipients include various compounds such as sugars, polymers, and proteins that support drug formulation and administration. The main product types of biopharmaceutical excipients are binders, coatings, diluents, disintegrants, lubricants and glidants, polyols, preservatives, solubilizers and surfactants or emulsifiers, and suspending and viscosity agents. Binders are substances added to powders or granules in pharmaceutical, food, or material formulations to hold the ingredients together, providing cohesion and structural integrity to the final product. Different types of biologics are antibodies, vaccines, cell therapies, and others. The multiple functionalities are fillers and diluents, binders, suspending and viscosity agents, flavouring agents and sweeteners, coating agents, colourants, disintegrants, lubricants and glidants, and preservatives. The various applications involved are injectable formulations, oral formulations, topical formulations, transdermal formulations, and cell and gene therapies, and they are used by several end users such as biopharmaceutical companies and pharmaceutical companies, contract manufacturers, and research institutes.

What Is The Biopharmaceutical Excipients Market Growth Forecast?

The biopharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $5.04 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing complexity of biologic formulations, rising demand for long shelf-life products, expansion of cell and gene therapies, growing regulatory focus on excipient safety, increasing investments in advanced drug delivery systems. Major trends in the forecast period include increasing demand for high-purity biologic excipients, growing use of multifunctional formulation ingredients, expansion of excipients for cell and gene therapies, rising focus on stability-enhancing compounds, enhanced customization of excipient solutions.

Global Biopharmaceutical Excipients Market Segmentation

1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents 2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics 3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives 4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy 5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes Subsegments: 1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders 2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings 3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol 4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate 5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide 6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol 7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols 8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate 9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers

What Is The Driver Of The Biopharmaceutical Excipients Market?

The growing demand for vaccine development is expected to propel the growth of the biopharmaceutical excipients market going forward. Vaccine development refers to the process of creating and formulating immunizations that prevent infectious diseases and improve public health, relying on high-quality excipients to ensure the stability, efficacy, and safety of vaccine products. The increasing demand for vaccine development stems from the global focus on preventing infectious diseases, strengthening public health preparedness, and accelerating research to deliver faster and more effective immunization solutions. Biopharmaceutical excipients play a critical role in vaccine formulations by stabilizing antigens, enhancing solubility, and maintaining integrity during storage and distribution. For instance, in 2025, according to the Centers for Disease Control and Prevention, a US-based national public health agency, adolescent vaccination coverage for key vaccines such as tetanus, diphtheria, and acellular pertussis increased from 89.9% in 2022 to 91.3% in 2024, meningococcal conjugate vaccine coverage rose from 88.6% to 90.1%; and human papillomavirus vaccine coverage (≥2 doses) grew significantly from 76.0% to 92.6% over the same period. Therefore, the growing demand for vaccine development is driving the growth of the biopharmaceutical excipients industry.

Key Players In The Global Biopharmaceutical Excipients Market

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

Global Biopharmaceutical Excipients Market Trends and Insights

Major companies operating in the biopharmaceutical excipients market are focusing on technological innovation, such as ultra-high purity surfactants, to improve protein stability, prevent degradation, and support regulatory compliance in injectable formulations. Ultra-high purity surfactants are specially refined surface-active agents with minimal impurities and consistent composition, designed to ensure stability, safety, and performance in sensitive pharmaceutical and biopharmaceutical formulations. For instance, in September 2025, Evonik Industries AG, a Germany-based chemicals company, launched MaxiPure Polysorbate 80 for injectable and biopharmaceutical applications. The excipient is engineered with an oleic acid content exceeding ninety-eight percent, exceptional clarity, and full compliance with European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia standards. It addresses critical challenges in protein stability, prevents oxidative degradation, enables consistent solubilization of hydrophobic active pharmaceutical ingredients, and strengthens formulation reliability. By integrating this excipient, Evonik helps pharmaceutical and biopharmaceutical companies develop complex biologics and injectable therapies efficiently while ensuring safety and compliance.

What Are Latest Mergers And Acquisitions In The Biopharmaceutical Excipients Market?

In May 2025, Roquette Frères, a France-based pharmaceutical excipient, acquired International Flavors & Fragrances (IFF) Pharma Solutions for an undisclosed amount. Through this acquisition, Roquette strengthened its pharmaceutical excipients portfolio by integrating IFF Pharma Solutions’ expertise and innovative product range, enhancing its ability to deliver high-value drug delivery solutions and support the development of advanced pharmaceutical formulations worldwide. International Flavors & Fragrances Inc. is a US-based company that provides pharmaceutical excipients and functional ingredients through its IFF Pharma Solutions division, supporting drug formulation and delivery in the biopharmaceutical excipients.

Regional Insights

North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biopharmaceutical Excipients Market?

The biopharmaceutical excipients market consists of sales of growth media, buffer solutions, stabilizers, cryoprotectants, preservatives, surfactants, salts, amino acids, sugars. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biopharmaceutical Excipients Market Report 2026?

The biopharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical excipients industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.